Tryptophan Metabolism in Renal Carcinoma
Author Information
Author(s): G. AllegrI, C. A. Benassi, E. Boccu', A. De Nadai, B. Perissinotto
Primary Institution: Institute of Pharmaceutical Chemistry, University of Padua
Hypothesis
The study investigates the relationship between tryptophan metabolite excretion and renal tumors.
Conclusion
The study found that tryptophan metabolites in urine of kidney tumor patients are not derived from the tumor's own catabolism.
Supporting Evidence
- Normal kidneys lack tryptophan pyrrolase, while neoplastic tissues show comparable activities of kynureninase and kynurenine transaminase.
- Some patients excrete normal amounts of tryptophan metabolites before surgery, while others show increased excretion of certain metabolites.
- The study suggests that abnormal levels of urinary metabolites are not directly related to tumor enzymatic activity.
Takeaway
Doctors looked at how certain substances from tryptophan in the body are related to kidney tumors, and they found that these substances don't come from the tumors themselves.
Methodology
The study measured enzyme activities in 23 renal tumors and compared them with normal kidney tissue.
Limitations
The study could not obtain normal kidney tissue as a control, and the sample size was limited to 23 tumors.
Want to read the original?
Access the complete publication on the publisher's website